Understand the source comparison
DSIP vs Epithalon: Research Peptide Comparison
Primary Mechanism Hypothalamic sleep regulation, delta wave modulation, GABA-ergic pathway interaction Telomerase activation, telomere elongation, pineal gland melatonin restoration Distinct biological targets. DSIP modulates circadian processes; Epithalon tar
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Primary Mechanism
- Hypothalamic sleep regulation, delta wave modulation, GABA-ergic pathway interaction
- Telomerase activation, telomere elongation, pineal gland melatonin restoration
- Distinct biological targets. DSIP modulates circadian processes; Epithalon targets cellular aging at the chromosomal level
- Half-Life
- 30–45 minutes (rapid degradation, acute dosing required)
- Approximately 2–4 hours (effects persist 6–8 weeks post-cycle via sustained telomerase activity)
- DSIP requires precise timing relative to sleep phase; Epithalon allows flexible administration within treatment cycles
- Evidence Base
- 50+ years preclinical research; limited human RCTs; strongest evidence for stress-cortisol modulation and delta sleep enhancement in animal models
- Dominated by Russian gerontology studies; telomere lengthening demonstrated in aged rats and humans; 12-year mortality reduction study in elderly patients
- Epithalon has stronger longevity endpoint data; DSIP has clearer acute neurophysiological effects but lacks large-scale human trials
- Research Application
- Circadian biology, neuroprotection in ischemia models, stress resilience, opioid withdrawal studies
- Aging biomarkers, cellular senescence, telomere biology, age-related disease models
- Choose based on research question. Circadian/neuroprotection (DSIP) vs lifespan/cellular aging (Epithalon)
- Typical Dosing Protocol
- 0.1–1.0 mg IV/SC, administered 60–90 minutes pre-sleep phase, daily for 7–21 days in chronic studies
- 5–10 mg SC/IM daily for 10–20 days, repeated every 3–6 months; cyclical dosing mirrors published longevity protocols
- DSIP requires daily administration during active study phase; Epithalon uses intermittent cycles with prolonged off-periods
- Stability & Storage
- Lyophilized at −20°C; reconstituted solution stable 28 days at 2–8°C; highly susceptible to peptidase degradation
- Lyophilized at −20°C; reconstituted solution stable 28 days at 2–8°C; tetrapeptide structure offers slightly better enzymatic resistance
- Both require identical cold-chain handling; any temperature excursion above 8°C causes irreversible protein denaturation
- Measurement Requirements
- Polysomnography for delta wave quantification, actigraphy for circadian phase, cortisol sampling for stress studies
- qPCR telomere length analysis (pre/post treatment), melatonin circadian amplitude, oxidative stress biomarkers
- Epithalon requires expensive molecular assays; DSIP endpoints are more accessible but still require specialized equipment for publication-grade data